Bank Of Nova Scotia Bausch Health Companies Inc. Transaction History

Bank Of Nova Scotia

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $4,121 - $5,204	536 Added 2.6%	21,162 $173,000
Q2 2023 Aug 03, 2023	BUY	$5.72 - $8.8 $117,980 - $181,508	20,626 New	20,626 $165,000
Q3 2022 Nov 10, 2022	SELL	$4.58 - $9.21 $8.82 Million - $17.7 Million	-1,926,207 Reduced 83.33%	385,339 $2.66 Million
Q2 2022 Aug 08, 2022	BUY	$7.06 - $23.63 $16.3 Million - $54.6 Million	2,311,546 New	2,311,546 $19.4 Million
Q2 2022 Aug 05, 2022	SELL	$7.06 - $23.63 $16.4 Million - $54.7 Million	-2,315,944 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$21.6 - $27.79 $57,132 - $73,504	2,645 Added 0.11%	2,315,944 $52.9 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $7,728 - $9,747	-336 Reduced 0.01%	2,313,299 $63.9 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $3.56 Million - $4.28 Million	-142,271 Reduced 5.79%	2,313,635 $64.5 Million
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $67.4 Million - $80.3 Million	2,455,906 New	2,455,906 $72.1 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.